MicroRNA-197 influences 5-fluorouracil resistance via thymidylate synthase in colorectal cancer

被引：0
|
作者：
Z. Sun
N. Zhou
Q. Han
L. Zhao
C. Bai
Y. Chen
J. Zhou
R. C. Zhao
机构：
[1] Peking Union Medical College Hospital,Department of Oncology
[2] Chinese Academy of Medical Sciences and Peking Union Medical College,Institute of Basic Medical Sciences Chinese Academy of Medical Sciences
[3] School of Basic Medicine Peking Union Medical College,Department of Digestion
[4] Peking Union Medical College Hospital,Center of Translational Medicine
[5] Chinese Academy of Medical Sciences and Peking Union Medical College,undefined
[6] Peking Union Medical College Hospital,undefined
来源：
Clinical and Translational Oncology | 2015年 / 17卷
关键词：
miR-197; 5-Fluorouracil; Resistance; Thymidylate synthase; Colorectal cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：876 / 883
页数：7
相关论文
共 50 条
  • [1] MicroRNA-197 influences 5-fluorouracil resistance via thymidylate synthase in colorectal cancer
    Sun, Z.
    Zhou, N.
    Han, Q.
    Zhao, L.
    Bai, C.
    Chen, Y.
    Zhou, J.
    Zhao, R. C.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2015, 17 (11): : 876 - 883
  • [2] Dihydropyrimidine dehydrogenase but not thymidylate synthase expression is associated with resistance to 5-fluorouracil in colorectal cancer
    Nita, ME
    Tominaga, O
    Tsuruo, T
    Muto, T
    HEPATO-GASTROENTEROLOGY, 1998, 45 (24) : 2117 - 2122
  • [3] Validation of biomarkers associated with 5-fluorouracil and thymidylate synthase in colorectal cancer
    Xi, Yaguang
    Formentini, Andrea
    Nakajima, Go
    Kornmann, Marko
    Ju, Jingfang
    ONCOLOGY REPORTS, 2008, 19 (01) : 257 - 262
  • [4] Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism
    Peters, GJ
    Backus, HHJ
    Freemantle, S
    van Triest, B
    Codacci-Pisanelli, G
    van der Wilt, CL
    Smid, K
    Lunec, J
    Calvert, AH
    Marsh, S
    McLeod, HL
    Bloemena, E
    Meijer, S
    Jansen, G
    van Groeningen, CJ
    Pinedo, HM
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2002, 1587 (2-3): : 194 - 205
  • [5] MicroRNA-375-3p enhances chemosensitivity to 5-fluorouracil by targeting thymidylate synthase in colorectal cancer
    Xu, Fei
    Ye, Ming-Liang
    Zhang, Yu-Peng
    Li, Wen-Jie
    Li, Meng-Ting
    Wang, Hai-Zhou
    Qiu, Xiao
    Xu, Yan
    Yin, Jin-Wen
    Hu, Qian
    Wei, Wan-Hui
    Chang, Ying
    Liu, Lan
    Zhao, Qiu
    CANCER SCIENCE, 2020, 111 (05) : 1528 - 1541
  • [6] Thymidylate synthase polymorphism and survival of colorectal cancer patients treated with 5-fluorouracil
    Ulrich, CM
    Potter, JD
    BRITISH JOURNAL OF CANCER, 2002, 86 (08) : 1365 - 1365
  • [7] Thymidylate synthase polymorphism and survival of colorectal cancer patients treated with 5-fluorouracil
    C M Ulrich
    J D Potter
    British Journal of Cancer, 2002, 86 : 1365 - 1365
  • [8] Studies on thymidylate synthase structure involved in the prognosis and 5-fluorouracil resistance of human colorectal cancer.
    Sanguedolce, R
    Alessandro, R
    De Leo, G
    Gullotti, L
    Sanguedolce, F
    Vultaggio, G
    Diana, G
    Cirello, B
    Rausa, L
    ANNALS OF ONCOLOGY, 2000, 11 : 57 - 57
  • [9] A polymorphism in the enhancer region of the thymidylate synthase promoter influences the survival of colorectal cancer patients treated with 5-fluorouracil
    Iacopetta, B
    Grieu, F
    Joseph, D
    Elsaleh, H
    BRITISH JOURNAL OF CANCER, 2001, 85 (06) : 827 - 830
  • [10] A polymorphism in the enhancer region of the thymidylate synthase promoter influences the survival of colorectal cancer patients treated with 5-fluorouracil
    B Iacopetta
    F Grieu
    D Joseph
    H Elsaleh
    British Journal of Cancer, 2001, 85 : 827 - 830
12345